PODOLSKI JOSEPH S
No ORCID on file
· 980 papers in corpus
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…